Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma.

Sneddon S, Rive CM, Ma S, Dick IM, Allcock RJN, Brown SD, Holt RA, Watson M, Leary S, Lee YCG, Robinson BWS, Creaney J. Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma. Oncoimmunology. 2020; 9(1):1684713.

View in: PubMed

subject areas

Antigens, Neoplasm
CD8-Positive T-Lymphocytes
Humans
Immunotherapy
Receptors, Cell Surface

authors with profiles

Robert Holt

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support